HRGN- Harvard Apparatus Regenerative Technology, Inc.
Harvard Apparatus Regenerative Technology, Inc. (HRGN) has 8 insiders with recent SEC Form 4 filings, including 10 buys and 0 sells. HRGN is classified in the Biotechnology industry within the Health Care sector.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 280.6K | $420.9K | - | |
| Dir | 18.6K | $27.9K | - | |
| Dir | 18.6K | $27.9K | - | |
| Dir | 18.6K | $27.9K | - | |
| Dir | 18.6K | $27.9K | - |
Activity
Buys and sells only
Transactions
10 filings
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 25, 2025 | He Junli | CEO | Buy | 3,000 | $1.70 | $5,100.00 | +1.1% | |
| Sep 30, 2025 | He Junli | CEO | Buy | 300 | $1.98 | $594.00 | +0.1% | |
| Sep 2, 2025 | He Junli | CEO | Buy | 11,225 | $1.85 | $20,766.25 | +4.2% | |
| Aug 21, 2025 | He Junli | CEO | Buy | 4,050 | $1.72 | $6,966.00 | +1.5% | |
| Dec 24, 2024 | He Junli | CEO | Buy | 2,299 | $2.87 | $6,598.13 | +0.9% | |
| Aug 27, 2024 | He Junli | CEO | Buy | 5,101 | $3.37 | $17,190.37 | +2.0% | |
| Jun 21, 2024 | He Junli | CEO | Buy | 1,600 | $2.80 | $4,480.00 | +0.6% | |
| Dec 27, 2023 | He Junli | CEO | Buy | 2,700 | $4.76 | $12,852.00 | +1.1% | |
| Dec 14, 2023 | He Junli | CEO | Buy | 900 | $4.92 | $4,428.00 | +0.4% | |
| Dec 6, 2023 | He Junli | CEO | Buy | 1,500 | $5.07 | $7,605.00 | +0.6% |
Page 1Next →